{"id":"W4390905440","doi":"10.25251/skin.8.supp.305","title":"Bimekizumab 3-year Safety and Tolerability in Moderate to Severe Plaque Psoriasis: Long-term Pooled Analysis from Five Phase 3/3b Trials","year":2024,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Cilag; Manchester Biomedical Research Centre; Galderma; Meiji Seika Pharma; Astellas Pharma; Celltrion; Eisai; UCB Pharma; Valeant Pharmaceuticals International; Argenx; Pfizer; Biogen; Incyte; Genentech; Torii Pharmaceutical; Dalhousie University; Castle Biosciences; Sun Pharma; Dermira; Universität zu Lübeck; Regeneron Pharmaceuticals; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Celgene; Yale University; Sanofi; Amgen; LEO Pharma; Ortho Dermatologics; AstraZeneca; Eli Lilly and Company; Samsung; Bristol-Myers Squibb","keywords":"Tolerability; Plaque psoriasis; Medicine; Term (time); Pooled analysis; Psoriasis; Internal medicine; Dermatology; Adverse effect; Meta-analysis; Physics","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01191728,0.001912079,0.007286994,0.0007790375,0.0005294073,0.00248843,0.0009966566,0.001575009,0.002041566],"category_scores_gemma":[0.006416902,0.0008223829,0.01391406,0.001188226,0.000720563,0.001510842,0.0008534904,0.002898011,0.0003765787],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001002493,"about_ca_system_score_gemma":0.0009391695,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001069294,"about_ca_topic_score_gemma":0.002171604,"domain_scores_codex":[0.9962231,0.002033426,0.0004065607,0.0005890852,0.0004102965,0.0003375175],"domain_scores_gemma":[0.995303,0.002019741,0.001356154,0.0005784552,0.0003864397,0.0003562162],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.6473709,0.001010315,0.01988617,0.009931461,0.243125,0.0001908455,0.0001798817,0.00466598,0.005146252,0.0001907867,0.002957012,0.06534529],"study_design_scores_gemma":[0.3584816,0.07471804,0.1565356,0.001447007,0.3928716,0.0008362928,0.0003148467,0.003416437,0.002670104,0.001264409,0.007165277,0.0002787265],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7484044,0.2395663,0.003199774,0.0006116942,0.0005261979,0.0009073816,0.003856752,0.0002287535,0.002698679],"genre_scores_gemma":[0.9741088,0.01971397,0.0009768273,0.0007408296,0.0003292615,0.0005860075,0.002663869,0.00005752192,0.0008229513],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01191728,"threshold_uncertainty_score":0.06302536,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01961196471794321,"score_gpt":0.2987783210275541,"score_spread":0.279166356309611,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}